Evidence map›Paper›PMID 40303156›Full record

ArticleTransboundary and emerging diseases2024

Scoping Review of Deep Learning Techniques for Diagnosis, Drug Discovery, and Vaccine Development in Leishmaniasis.

Alireza Sadeghi, Mahdieh Sadeghi, Mahdi Fakhar, Zakaria Zakariaei, Mohammadreza Sadeghi

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Transboundary and emerging diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alireza SadeghiIntelligent Mobile Robot Lab (IMRL), Department of Mechatronics Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran.ORCID https://orcid.org/0009-0006-3481-3714
Mahdieh SadeghiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0009-0005-3535-9245
Mahdi FakharToxoplasmosis Research Center, Iranian National Registry Center for Lophomoniasis and Toxoplasmosis, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-4690-6938
Zakaria ZakariaeiToxicology and Forensic Medicine Division, Mazandaran Registry Center for Opioids Poisoning, Antimicrobial Resistance Research Center, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0003-4835-9349
Mohammadreza SadeghiStudent Research Committee, Sari Branch, Islamic Azad University, Sari, Iran.ORCID https://orcid.org/0009-0002-9029-7524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Deep LearningDrug DiscoveryLeishmaniasisLeishmaniasis VaccinesVaccine DevelopmentAnimalsAntiprotozoal AgentsHumansLeishmaniaAntiprotozoal AgentsLeishmaniasis Vaccines

Identifiers

PMID40303156
PMCPMC12019899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.